Oncogenic Characterization and Pharmacologic Sensitivity of Activating Fibroblast Growth Factor Receptor (FGFR) Genetic Alterations to the Selective FGFR Inhibitor Erdafitinib
激活成纤维细胞生长因子受体 (FGFR) 基因变异对选择性 FGFR 抑制剂厄达替尼的致癌特性和药理敏感性
期刊:Molecular Cancer Therapeutics
影响因子:5.3
doi:10.1158/1535-7163.MCT-16-0518
Jayaprakash D Karkera, Gabriela Martinez Cardona, Katherine Bell, Dana Gaffney, Joseph C Portale, Ademi Santiago-Walker, Christopher H Moy, Peter King, Michael Sharp, Rastislav Bahleda, Feng R Luo, John D Alvarez, Matthew V Lorenzi, Suso J Platero